Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2016-04-06 | Dr. Wider is a surgeon and has served as consultant to numerous entities in the biotechnology space. |
| 2017-04-11 | Dr. Wider’s qualifications to serve our Board include his biotechnology expertise as well as his experience as a surgeon. |
| 2018-04-10 | Dr. Wider’s qualifications to serve our Board include his biotechnology expertise as well as his experience as a surgeon. |
| 2019-04-11 | Dr. Wider’s qualifications to serve our Board include his biotechnology expertise as well as his experience as a surgeon. |
| 2020-04-10 | Dr. Wider’s qualifications to serve our Board include his biotechnology expertise as well as his experience as a surgeon. |
| 2021-04-09 | Todd Wider, M.D., 56, became a director in May 2015 and currently serves as a member of the Compensation Committee and the Governance and Nominating Committee. |
| 2022-05-12 | Directors and Named Executive Officers: Todd Wider, M.D. |
| 2022-07-11 | Dr. Wider is a surgeon and has served as consultant to numerous entities in the biotechnology space. |
| 2023-04-13 | Todd Wider, M.D., 58, became a director in May 2015. |
| 2024-11-12 | The table below represents the compensation paid to each of our directors who served on the Board during the year ended December 31, 2023. |
Data sourced from SEC filings. Last updated: 2025-07-01